Brian Piekos
Finanzdirektor/CFO bei ELICIO THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Brian Piekos
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ELICIO THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.05.2023 | - |
Karriereverlauf von Brian Piekos
Ehemalige bekannte Positionen von Brian Piekos
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GEMI THER | Comptroller/Controller/Auditor | 17.02.2021 | 29.12.2022 |
| Finanzdirektor/CFO | 09.02.2021 | 29.12.2022 | |
| AMAG PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 11.06.2020 | 01.12.2020 |
| Finanzdirektor/CFO | 11.06.2020 | 01.12.2020 | |
| Corporate Officer/Principal | 01.09.2015 | 11.06.2020 | |
| Treasurer | 11.06.2020 | 01.12.2020 | |
| CUBIST PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01.08.2010 | 01.02.2015 |
| Treasurer | 01.08.2010 | 01.02.2015 | |
| SCPHARMACEUTICALS INC. | Finanzdirektor/CFO | 14.04.2015 | - |
Ausbildung von Brian Piekos
| University of Rochester Simon Business School | Masters Business Admin |
| UMass Chan Medical School | Graduate Degree |
| Ithaca College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
Operativ
| Director of Finance/CFO | 4 |
| Comptroller/Controller/Auditor | 3 |
| Treasurer | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SCPHARMACEUTICALS INC. | Health Technology |
| ELICIO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
- Börse
- Insiders
- Brian Piekos
- Erfahrung
